| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urea Cycle Disorders, Inborn | 8 | 2023 | 80 | 2.540 |
Why?
|
| Intellectual Disability | 16 | 2024 | 1061 | 2.120 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 5 | 2022 | 102 | 2.110 |
Why?
|
| Osteochondrodysplasias | 3 | 2019 | 74 | 1.590 |
Why?
|
| Argininosuccinate Lyase | 3 | 2021 | 64 | 1.570 |
Why?
|
| Genetic Association Studies | 7 | 2024 | 1065 | 1.440 |
Why?
|
| Phenotype | 29 | 2024 | 6465 | 1.270 |
Why?
|
| Developmental Disabilities | 10 | 2024 | 690 | 1.240 |
Why?
|
| Lipid Metabolism, Inborn Errors | 3 | 2015 | 19 | 1.170 |
Why?
|
| Metabolism, Inborn Errors | 4 | 2022 | 108 | 1.070 |
Why?
|
| Ectodermal Dysplasia | 2 | 2024 | 46 | 1.010 |
Why?
|
| Collagen Type II | 2 | 2016 | 38 | 1.000 |
Why?
|
| Liver Diseases | 2 | 2021 | 605 | 0.990 |
Why?
|
| Child, Preschool | 36 | 2024 | 16978 | 0.990 |
Why?
|
| Chromosome Deletion | 5 | 2018 | 1056 | 0.980 |
Why?
|
| Heterozygote | 6 | 2024 | 1032 | 0.980 |
Why?
|
| Lung Diseases | 3 | 2021 | 751 | 0.980 |
Why?
|
| Microcephaly | 3 | 2022 | 333 | 0.970 |
Why?
|
| Genetic Diseases, Inborn | 4 | 2021 | 455 | 0.960 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 20 | 0.960 |
Why?
|
| Growth Disorders | 2 | 2016 | 224 | 0.950 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2024 | 157 | 0.920 |
Why?
|
| Propionic Acidemia | 2 | 2022 | 11 | 0.910 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2014 | 102 | 0.910 |
Why?
|
| Mutation | 18 | 2024 | 15854 | 0.910 |
Why?
|
| Autism Spectrum Disorder | 3 | 2023 | 374 | 0.850 |
Why?
|
| Hyperammonemia | 5 | 2023 | 67 | 0.840 |
Why?
|
| Muscular Diseases | 3 | 2022 | 163 | 0.800 |
Why?
|
| Craniosynostoses | 1 | 2024 | 133 | 0.790 |
Why?
|
| Genetic Variation | 7 | 2022 | 2087 | 0.790 |
Why?
|
| Filamins | 2 | 2021 | 33 | 0.780 |
Why?
|
| Aniridia | 1 | 2021 | 17 | 0.770 |
Why?
|
| Child | 43 | 2024 | 30418 | 0.770 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 38 | 0.760 |
Why?
|
| Metabolomics | 3 | 2022 | 507 | 0.750 |
Why?
|
| Muscle Hypotonia | 7 | 2023 | 183 | 0.730 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 72 | 0.720 |
Why?
|
| Phenylbutyrates | 3 | 2023 | 63 | 0.710 |
Why?
|
| Liver Glycogen | 1 | 2020 | 28 | 0.710 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 649 | 0.710 |
Why?
|
| Dwarfism | 3 | 2015 | 110 | 0.710 |
Why?
|
| Introns | 1 | 2021 | 460 | 0.690 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2015 | 19 | 0.660 |
Why?
|
| Diet | 7 | 2015 | 1484 | 0.660 |
Why?
|
| Neurodevelopmental Disorders | 4 | 2024 | 456 | 0.650 |
Why?
|
| Micrognathism | 3 | 2017 | 67 | 0.650 |
Why?
|
| Phenylketonurias | 2 | 2023 | 24 | 0.640 |
Why?
|
| Congenital Abnormalities | 2 | 2018 | 278 | 0.640 |
Why?
|
| Exome | 11 | 2023 | 1248 | 0.630 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 2 | 2018 | 23 | 0.630 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 77 | 0.620 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2017 | 6 | 0.600 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 229 | 0.600 |
Why?
|
| Chromosomes, Mammalian | 5 | 2011 | 61 | 0.590 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2018 | 186 | 0.590 |
Why?
|
| Alleles | 9 | 2024 | 2508 | 0.590 |
Why?
|
| Infant | 24 | 2024 | 13913 | 0.590 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 373 | 0.590 |
Why?
|
| Larynx | 1 | 2018 | 143 | 0.570 |
Why?
|
| Carnitine | 3 | 2018 | 87 | 0.570 |
Why?
|
| Mitochondrial Diseases | 2 | 2015 | 145 | 0.570 |
Why?
|
| Liver Transplantation | 4 | 2023 | 1184 | 0.570 |
Why?
|
| Seizures | 9 | 2023 | 1048 | 0.560 |
Why?
|
| Argininosuccinic Aciduria | 3 | 2023 | 51 | 0.560 |
Why?
|
| Hip Joint | 1 | 2016 | 58 | 0.550 |
Why?
|
| Tibial Fractures | 1 | 2016 | 63 | 0.540 |
Why?
|
| Geminin | 1 | 2015 | 9 | 0.530 |
Why?
|
| Pneumonectomy | 1 | 2021 | 863 | 0.530 |
Why?
|
| Chromosome Disorders | 1 | 2018 | 425 | 0.530 |
Why?
|
| Hyperargininemia | 1 | 2015 | 13 | 0.520 |
Why?
|
| Congenital Microtia | 1 | 2015 | 15 | 0.520 |
Why?
|
| Patella | 1 | 2015 | 39 | 0.520 |
Why?
|
| Quantitative Trait Loci | 8 | 2011 | 337 | 0.520 |
Why?
|
| Fibroblasts | 8 | 2024 | 1669 | 0.510 |
Why?
|
| Arginase | 1 | 2015 | 42 | 0.510 |
Why?
|
| Biomarkers | 4 | 2021 | 5106 | 0.500 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2015 | 39 | 0.500 |
Why?
|
| Humans | 84 | 2024 | 270946 | 0.500 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2024 | 5438 | 0.490 |
Why?
|
| Adolescent | 28 | 2024 | 32577 | 0.490 |
Why?
|
| Fractures, Bone | 1 | 2017 | 312 | 0.480 |
Why?
|
| Mitochondrial Myopathies | 1 | 2014 | 29 | 0.470 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2014 | 16 | 0.470 |
Why?
|
| Acidosis, Lactic | 1 | 2014 | 35 | 0.470 |
Why?
|
| Obesity | 7 | 2012 | 2940 | 0.460 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 532 | 0.460 |
Why?
|
| Female | 57 | 2024 | 148508 | 0.460 |
Why?
|
| Fasting | 1 | 2015 | 350 | 0.460 |
Why?
|
| Anemia, Sideroblastic | 1 | 2014 | 58 | 0.460 |
Why?
|
| DNA Copy Number Variations | 4 | 2024 | 1543 | 0.450 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 348 | 0.450 |
Why?
|
| Muscle Proteins | 1 | 2017 | 557 | 0.450 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 1022 | 0.450 |
Why?
|
| Pedigree | 8 | 2022 | 1983 | 0.430 |
Why?
|
| Trisomy | 2 | 2012 | 239 | 0.430 |
Why?
|
| Rare Diseases | 3 | 2024 | 360 | 0.430 |
Why?
|
| Male | 50 | 2024 | 128453 | 0.420 |
Why?
|
| Lung Transplantation | 1 | 2017 | 389 | 0.420 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 313 | 0.410 |
Why?
|
| Arginine | 1 | 2015 | 509 | 0.400 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 471 | 0.400 |
Why?
|
| Uniparental Disomy | 1 | 2012 | 56 | 0.400 |
Why?
|
| Genetics, Medical | 2 | 2023 | 140 | 0.400 |
Why?
|
| NF-kappa B | 1 | 2019 | 1583 | 0.400 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 154 | 0.400 |
Why?
|
| Prader-Willi Syndrome | 1 | 2012 | 69 | 0.400 |
Why?
|
| Disease Models, Animal | 9 | 2023 | 7461 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2012 | 201 | 0.390 |
Why?
|
| Kidney | 1 | 2020 | 2261 | 0.380 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 603 | 0.380 |
Why?
|
| Mosaicism | 1 | 2013 | 289 | 0.370 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 360 | 0.370 |
Why?
|
| DNA Damage | 1 | 2019 | 1980 | 0.370 |
Why?
|
| Mutation, Missense | 7 | 2024 | 1182 | 0.360 |
Why?
|
| Epilepsy, Generalized | 2 | 2021 | 73 | 0.350 |
Why?
|
| Mice | 24 | 2023 | 35992 | 0.350 |
Why?
|
| Young Adult | 18 | 2024 | 22059 | 0.350 |
Why?
|
| Infant, Newborn | 15 | 2022 | 8591 | 0.350 |
Why?
|
| Exons | 5 | 2022 | 1379 | 0.340 |
Why?
|
| Animals | 30 | 2023 | 62771 | 0.330 |
Why?
|
| Leukoencephalopathies | 2 | 2020 | 61 | 0.330 |
Why?
|
| Limb Deformities, Congenital | 2 | 2024 | 117 | 0.320 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2023 | 2335 | 0.320 |
Why?
|
| DNA-Binding Proteins | 5 | 2023 | 5042 | 0.310 |
Why?
|
| Mice, Knockout | 4 | 2023 | 5837 | 0.310 |
Why?
|
| Loss of Function Mutation | 3 | 2024 | 153 | 0.300 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2023 | 1467 | 0.300 |
Why?
|
| Autistic Disorder | 2 | 2021 | 346 | 0.300 |
Why?
|
| Bone and Bones | 2 | 2021 | 612 | 0.300 |
Why?
|
| Neonatal Screening | 4 | 2019 | 187 | 0.290 |
Why?
|
| Genes, Dominant | 2 | 2020 | 351 | 0.290 |
Why?
|
| Trans-Activators | 1 | 2013 | 1655 | 0.270 |
Why?
|
| Abnormalities, Multiple | 3 | 2018 | 1016 | 0.270 |
Why?
|
| Syndrome | 5 | 2024 | 1404 | 0.260 |
Why?
|
| Genotype | 7 | 2019 | 4109 | 0.250 |
Why?
|
| Amino Acid Sequence | 6 | 2020 | 4644 | 0.250 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2023 | 143 | 0.250 |
Why?
|
| Hand Deformities, Congenital | 2 | 2017 | 95 | 0.240 |
Why?
|
| Craniofacial Abnormalities | 2 | 2019 | 248 | 0.240 |
Why?
|
| RNA, Small Nuclear | 1 | 2024 | 55 | 0.240 |
Why?
|
| Adult | 21 | 2024 | 81555 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2018 | 663 | 0.230 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2024 | 82 | 0.230 |
Why?
|
| Base Sequence | 5 | 2023 | 5496 | 0.230 |
Why?
|
| Receptors, AMPA | 1 | 2024 | 83 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 2 | 2024 | 675 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 9 | 2023 | 7216 | 0.220 |
Why?
|
| Scleroderma, Systemic | 1 | 2024 | 160 | 0.220 |
Why?
|
| Ferrets | 1 | 2023 | 22 | 0.220 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 117 | 0.220 |
Why?
|
| Gain of Function Mutation | 1 | 2024 | 133 | 0.220 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2024 | 188 | 0.210 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2022 | 169 | 0.210 |
Why?
|
| Inheritance Patterns | 2 | 2015 | 134 | 0.210 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 2351 | 0.210 |
Why?
|
| Caenorhabditis elegans | 5 | 2023 | 282 | 0.210 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 2048 | 0.210 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2022 | 11 | 0.210 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 6789 | 0.210 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2022 | 19 | 0.200 |
Why?
|
| Epileptic Syndromes | 1 | 2022 | 28 | 0.200 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2022 | 19 | 0.200 |
Why?
|
| Calcium Channels, R-Type | 1 | 2021 | 2 | 0.200 |
Why?
|
| Cells, Cultured | 4 | 2020 | 5782 | 0.200 |
Why?
|
| Transposases | 1 | 2022 | 69 | 0.200 |
Why?
|
| Transcription Factors | 4 | 2023 | 5494 | 0.200 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2010 | 99 | 0.200 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 17 | 0.200 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2023 | 147 | 0.190 |
Why?
|
| Coatomer Protein | 1 | 2021 | 33 | 0.190 |
Why?
|
| F-Box Proteins | 1 | 2022 | 99 | 0.190 |
Why?
|
| Nitric Acid | 1 | 2021 | 6 | 0.190 |
Why?
|
| Syndactyly | 1 | 2021 | 27 | 0.190 |
Why?
|
| Facies | 1 | 2021 | 154 | 0.190 |
Why?
|
| Calcium Channels, L-Type | 1 | 2021 | 76 | 0.180 |
Why?
|
| Movement Disorders | 1 | 2023 | 236 | 0.180 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2020 | 26 | 0.180 |
Why?
|
| Protein Precursors | 1 | 2022 | 250 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 223 | 0.180 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 171 | 0.180 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 139 | 0.180 |
Why?
|
| Cation Transport Proteins | 1 | 2021 | 172 | 0.180 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2020 | 13 | 0.180 |
Why?
|
| Radiography | 2 | 2016 | 1990 | 0.180 |
Why?
|
| Job Syndrome | 1 | 2020 | 22 | 0.180 |
Why?
|
| Spectrin | 1 | 2021 | 83 | 0.180 |
Why?
|
| Long QT Syndrome | 1 | 2021 | 110 | 0.180 |
Why?
|
| Nuclear Proteins | 3 | 2022 | 3459 | 0.180 |
Why?
|
| Organ Transplantation | 1 | 2022 | 204 | 0.180 |
Why?
|
| Hedgehog Proteins | 1 | 2023 | 441 | 0.180 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 138 | 0.170 |
Why?
|
| Zebrafish | 2 | 2021 | 463 | 0.170 |
Why?
|
| Brain Diseases | 2 | 2020 | 417 | 0.170 |
Why?
|
| Liver Function Tests | 1 | 2019 | 186 | 0.170 |
Why?
|
| Face | 2 | 2018 | 251 | 0.170 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 240 | 0.170 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 31 | 0.170 |
Why?
|
| Osteoporosis | 1 | 2021 | 237 | 0.160 |
Why?
|
| Retrospective Studies | 12 | 2023 | 39694 | 0.160 |
Why?
|
| Symptom Assessment | 1 | 2021 | 274 | 0.160 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 166 | 0.160 |
Why?
|
| Nerve Degeneration | 1 | 2020 | 163 | 0.160 |
Why?
|
| Congenital Hyperinsulinism | 1 | 2018 | 3 | 0.160 |
Why?
|
| INDEL Mutation | 1 | 2019 | 113 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 323 | 0.160 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 496 | 0.160 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 137 | 0.160 |
Why?
|
| Osteoblasts | 1 | 2021 | 394 | 0.160 |
Why?
|
| Chromosome Mapping | 5 | 2014 | 1586 | 0.160 |
Why?
|
| Multiple Carboxylase Deficiency | 1 | 2018 | 3 | 0.160 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 186 | 0.150 |
Why?
|
| Amino Acids | 2 | 2020 | 787 | 0.150 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 127 | 0.150 |
Why?
|
| Neuroglia | 1 | 2020 | 251 | 0.150 |
Why?
|
| Glycolysis | 1 | 2021 | 533 | 0.150 |
Why?
|
| Skin | 2 | 2021 | 1290 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 143 | 0.150 |
Why?
|
| Genetic Testing | 3 | 2023 | 1668 | 0.150 |
Why?
|
| Sequence Alignment | 2 | 2018 | 885 | 0.150 |
Why?
|
| Homocystinuria | 1 | 2017 | 21 | 0.150 |
Why?
|
| Urea | 1 | 2019 | 306 | 0.150 |
Why?
|
| Vestibular Diseases | 1 | 2018 | 69 | 0.140 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2017 | 53 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2018 | 145 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 337 | 0.140 |
Why?
|
| Carrier Proteins | 4 | 2023 | 2123 | 0.140 |
Why?
|
| Hematologic Diseases | 1 | 2018 | 255 | 0.140 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 34 | 0.140 |
Why?
|
| Sexual Development | 1 | 2016 | 23 | 0.140 |
Why?
|
| Endothelial Cells | 2 | 2023 | 1045 | 0.140 |
Why?
|
| Epilepsy | 2 | 2024 | 982 | 0.140 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2016 | 38 | 0.140 |
Why?
|
| Axons | 1 | 2020 | 443 | 0.140 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 2083 | 0.140 |
Why?
|
| Bone Diseases, Developmental | 1 | 2016 | 70 | 0.140 |
Why?
|
| Glutathione Synthase | 1 | 2016 | 6 | 0.140 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 730 | 0.130 |
Why?
|
| Genes, Recessive | 1 | 2016 | 198 | 0.130 |
Why?
|
| Metalloendopeptidases | 1 | 2016 | 176 | 0.130 |
Why?
|
| Age of Onset | 2 | 2021 | 824 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 5 | 2015 | 2562 | 0.130 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2016 | 65 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 233 | 0.130 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2015 | 16 | 0.130 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 151 | 0.130 |
Why?
|
| Steroid Isomerases | 1 | 2015 | 13 | 0.130 |
Why?
|
| Food, Formulated | 1 | 2015 | 55 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 7951 | 0.130 |
Why?
|
| Arthrogryposis | 1 | 2015 | 34 | 0.130 |
Why?
|
| Myosins | 1 | 2015 | 97 | 0.120 |
Why?
|
| Micronutrients | 1 | 2015 | 76 | 0.120 |
Why?
|
| Homozygote | 1 | 2017 | 759 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 381 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 659 | 0.120 |
Why?
|
| Protein Stability | 1 | 2015 | 374 | 0.120 |
Why?
|
| Disease Management | 2 | 2017 | 1112 | 0.120 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.120 |
Why?
|
| Alopecia | 1 | 2015 | 123 | 0.120 |
Why?
|
| Crosses, Genetic | 3 | 2010 | 254 | 0.120 |
Why?
|
| Cell Respiration | 1 | 2014 | 54 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2020 | 1851 | 0.120 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2014 | 15 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 1076 | 0.120 |
Why?
|
| Cohort Studies | 5 | 2024 | 9433 | 0.120 |
Why?
|
| Actins | 1 | 2017 | 616 | 0.120 |
Why?
|
| Heart Defects, Congenital | 2 | 2016 | 1783 | 0.120 |
Why?
|
| Nails, Malformed | 1 | 2013 | 8 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2021 | 1934 | 0.120 |
Why?
|
| Bartonella henselae | 1 | 2013 | 23 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2015 | 359 | 0.110 |
Why?
|
| Proteolysis | 1 | 2015 | 380 | 0.110 |
Why?
|
| Brain | 4 | 2024 | 4257 | 0.110 |
Why?
|
| Cat-Scratch Disease | 1 | 2013 | 35 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 476 | 0.110 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2013 | 8 | 0.110 |
Why?
|
| Brachydactyly | 1 | 2013 | 10 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 254 | 0.110 |
Why?
|
| Flavoproteins | 1 | 2013 | 32 | 0.110 |
Why?
|
| Toes | 1 | 2013 | 48 | 0.110 |
Why?
|
| Cognition | 1 | 2019 | 983 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2020 | 2289 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 4327 | 0.110 |
Why?
|
| Neurons | 1 | 2024 | 2465 | 0.110 |
Why?
|
| Bone Development | 1 | 2013 | 83 | 0.110 |
Why?
|
| Internationality | 1 | 2013 | 202 | 0.100 |
Why?
|
| Homeostasis | 2 | 2011 | 960 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 542 | 0.100 |
Why?
|
| Cataract | 1 | 2015 | 230 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 183 | 0.100 |
Why?
|
| Hand | 1 | 2013 | 175 | 0.100 |
Why?
|
| Phenylalanine | 1 | 2012 | 167 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2015 | 909 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 15253 | 0.100 |
Why?
|
| Nucleotide Transport Proteins | 1 | 2011 | 2 | 0.100 |
Why?
|
| Infant Formula | 1 | 2012 | 94 | 0.100 |
Why?
|
| Point Mutation | 1 | 2014 | 791 | 0.100 |
Why?
|
| Liver | 1 | 2021 | 3126 | 0.090 |
Why?
|
| Genetics, Population | 2 | 2020 | 238 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 665 | 0.090 |
Why?
|
| Animals, Congenic | 1 | 2010 | 9 | 0.090 |
Why?
|
| Mitochondria, Liver | 1 | 2010 | 54 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 692 | 0.090 |
Why?
|
| Exosomes | 1 | 2013 | 252 | 0.090 |
Why?
|
| Hospitalization | 1 | 2019 | 2200 | 0.090 |
Why?
|
| Mice, Congenic | 4 | 2011 | 30 | 0.090 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2011 | 107 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2021 | 4191 | 0.090 |
Why?
|
| Body Size | 1 | 2010 | 67 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 3075 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2015 | 2151 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 6172 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2015 | 826 | 0.090 |
Why?
|
| Haploinsufficiency | 2 | 2021 | 303 | 0.090 |
Why?
|
| Maternal Exposure | 1 | 2011 | 153 | 0.080 |
Why?
|
| Birth Weight | 1 | 2011 | 350 | 0.080 |
Why?
|
| Oxidative Phosphorylation | 1 | 2010 | 267 | 0.080 |
Why?
|
| Weight Gain | 2 | 2010 | 475 | 0.080 |
Why?
|
| Overweight | 1 | 2012 | 484 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1613 | 0.080 |
Why?
|
| Epistasis, Genetic | 1 | 2008 | 109 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2011 | 748 | 0.080 |
Why?
|
| Middle Aged | 6 | 2024 | 90020 | 0.080 |
Why?
|
| Gene Expression | 1 | 2015 | 3681 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2314 | 0.070 |
Why?
|
| Nitric Oxide | 2 | 2023 | 665 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 4897 | 0.070 |
Why?
|
| Disease | 1 | 2008 | 159 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2022 | 265 | 0.070 |
Why?
|
| Sex Factors | 1 | 2012 | 2192 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2024 | 1526 | 0.070 |
Why?
|
| Premature Birth | 1 | 2011 | 403 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3349 | 0.070 |
Why?
|
| Sexual Maturation | 1 | 2006 | 67 | 0.070 |
Why?
|
| Genome | 1 | 2010 | 683 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 556 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 734 | 0.070 |
Why?
|
| Glucose | 1 | 2011 | 1249 | 0.060 |
Why?
|
| NIMA-Related Kinases | 1 | 2024 | 16 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2012 | 2237 | 0.060 |
Why?
|
| Prevalence | 1 | 2012 | 3420 | 0.060 |
Why?
|
| RNA Splice Sites | 1 | 2024 | 114 | 0.060 |
Why?
|
| Spliceosomes | 1 | 2024 | 75 | 0.060 |
Why?
|
| Body Weight | 4 | 2011 | 1333 | 0.060 |
Why?
|
| Claudins | 1 | 2023 | 56 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2023 | 260 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2011 | 1441 | 0.050 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2023 | 37 | 0.050 |
Why?
|
| Methylmalonic Acid | 1 | 2022 | 17 | 0.050 |
Why?
|
| Ligases | 1 | 2023 | 85 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2023 | 100 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2003 | 149 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2023 | 134 | 0.050 |
Why?
|
| Gait | 1 | 2023 | 155 | 0.050 |
Why?
|
| Cilia | 1 | 2023 | 91 | 0.050 |
Why?
|
| Separase | 1 | 2022 | 32 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2023 | 164 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 247 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 95 | 0.050 |
Why?
|
| Genomics | 2 | 2023 | 2817 | 0.050 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2022 | 51 | 0.050 |
Why?
|
| Pulmonary Surfactants | 1 | 2022 | 52 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2003 | 151 | 0.050 |
Why?
|
| Ammonia | 1 | 2022 | 89 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 565 | 0.050 |
Why?
|
| Nondisjunction, Genetic | 1 | 2001 | 21 | 0.050 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2001 | 32 | 0.050 |
Why?
|
| Prognosis | 1 | 2019 | 22458 | 0.050 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2021 | 28 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 130 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 154 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 245 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2001 | 186 | 0.050 |
Why?
|
| Problem Behavior | 1 | 2021 | 39 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2022 | 149 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2021 | 191 | 0.050 |
Why?
|
| Rats | 3 | 2020 | 6637 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2020 | 19 | 0.050 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 18 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 459 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 195 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 335 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2020 | 107 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 520 | 0.040 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 215 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2021 | 161 | 0.040 |
Why?
|
| Guanosine Diphosphate Fucose | 1 | 2018 | 3 | 0.040 |
Why?
|
| Guanosine Diphosphate Mannose | 1 | 2018 | 4 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2020 | 253 | 0.040 |
Why?
|
| Glycerol | 1 | 2019 | 107 | 0.040 |
Why?
|
| Fucosyltransferases | 1 | 2018 | 78 | 0.040 |
Why?
|
| Folic Acid | 1 | 2001 | 366 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 91 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 182 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 231 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 4399 | 0.040 |
Why?
|
| United States | 3 | 2023 | 15982 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2023 | 2109 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 143 | 0.040 |
Why?
|
| Infant Care | 1 | 2017 | 46 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 879 | 0.040 |
Why?
|
| Hydroxocobalamin | 1 | 2017 | 9 | 0.040 |
Why?
|
| White Matter | 1 | 2020 | 190 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2020 | 265 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 124 | 0.040 |
Why?
|
| Models, Animal | 2 | 2011 | 675 | 0.040 |
Why?
|
| Pregnancy | 3 | 2023 | 8043 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 2247 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2018 | 337 | 0.030 |
Why?
|
| Sex Determination Processes | 1 | 2016 | 15 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 1571 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 562 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2020 | 907 | 0.030 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2016 | 34 | 0.030 |
Why?
|
| Gonads | 1 | 2016 | 52 | 0.030 |
Why?
|
| Proteomics | 1 | 2023 | 1435 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2021 | 993 | 0.030 |
Why?
|
| Karyotype | 1 | 2016 | 237 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 1473 | 0.030 |
Why?
|
| Time Factors | 1 | 2010 | 13112 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 532 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2017 | 33827 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2001 | 1522 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 2214 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2017 | 405 | 0.030 |
Why?
|
| Genetic Carrier Screening | 1 | 2015 | 96 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1934 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2023 | 1732 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2023 | 12206 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2015 | 67 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 388 | 0.030 |
Why?
|
| Acidosis | 1 | 2016 | 115 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 294 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 1091 | 0.030 |
Why?
|
| Drosophila | 1 | 2020 | 911 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2017 | 451 | 0.030 |
Why?
|
| Mice, Inbred A | 2 | 2004 | 33 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 865 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 2465 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 902 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 377 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 268 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2015 | 221 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2020 | 908 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2015 | 264 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2013 | 149 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 45 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 132 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 706 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 390 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 1834 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 1201 | 0.030 |
Why?
|
| Ovary | 1 | 2016 | 701 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 234 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 1594 | 0.030 |
Why?
|
| Testis | 1 | 2016 | 753 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 1482 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2018 | 1158 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 420 | 0.020 |
Why?
|
| Newfoundland and Labrador | 1 | 2011 | 2 | 0.020 |
Why?
|
| Models, Biological | 1 | 2020 | 3226 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 1599 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 808 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 2836 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 147 | 0.020 |
Why?
|
| Lung | 1 | 2022 | 3267 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2011 | 130 | 0.020 |
Why?
|
| Stillbirth | 1 | 2011 | 86 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 3536 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 2012 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2011 | 168 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 4371 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 1522 | 0.020 |
Why?
|
| Body Height | 1 | 2011 | 232 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 4182 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 2490 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 4505 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 4732 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2009 | 53 | 0.020 |
Why?
|
| Aged | 1 | 2014 | 73160 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 2314 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2009 | 257 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 6415 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2008 | 350 | 0.020 |
Why?
|
| Adiposity | 1 | 2008 | 238 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 5186 | 0.020 |
Why?
|
| Triglycerides | 1 | 2009 | 618 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1574 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 2288 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2011 | 825 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2006 | 511 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 374 | 0.010 |
Why?
|
| Sterols | 1 | 2004 | 23 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 3494 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 13351 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 4331 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 1312 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2013 | 2953 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 613 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 747 | 0.010 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2001 | 16 | 0.010 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2001 | 57 | 0.010 |
Why?
|
| England | 1 | 2001 | 72 | 0.010 |
Why?
|
| Ohio | 1 | 2001 | 120 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2001 | 102 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 3177 | 0.010 |
Why?
|
| Meiosis | 1 | 2001 | 185 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 1080 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2001 | 1187 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 2001 | 449 | 0.010 |
Why?
|
| Anxiety | 1 | 2004 | 1235 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 17823 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2001 | 6027 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 2279 | 0.010 |
Why?
|